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Summary P-glycoprotein expression was demonstrated in two human intestinal adenocarcinoma cell-lines
(HCT-8, ileocaecal and T84, colonic) by immunoprecipitation of a 170-180 kDa protein with monoclonal
antibody JSB-1. Both HCT-8 and T84 formed functional epithelial cell layers of high transepithelial electrical
resistance (>700Q cm2) when grown on permeable matrices. These epithelial layers demonstrated vectorial
secretion (net vinblastine fluxes in the basal-to-apical direction of 0.135 and 0.452 pmol h-' cm-2 in HCT-8
and T84 cell layers, respectively, from bathing solutions containing 10 nM vinblastine). These vectorial
vinblastine secretions were sensitive to inhibition by verapamil. Passive transepithelial vinblastine permeation
was limited by the presence of intercellular (tight) junctions, as demonstrated by the high transepithelial
electrical resistance, and verapamil increased this passive vinblastine permeation concomitant with a reduction
in the electrical resistance. Cellular vinblastine loading was significantly greater from the basal side, and this
was also susceptible to inhibition by basal verapamil. The demonstration of vectorial transport of vinblastine
in human intestinal colonic adenocarcinoma cell layers is direct evidence in favour of the hypothesis that the
function of mdrl in epithelia from the gastrointestinal tract is to promote detoxification by a process of
epithelial secretion. This study also highlights that cellular vinblastine accumulation depends not only upon
P-glycoprotein function, but also upon differential apparent membrane permeabilities and the presence of
intercellular (tight) junctions that may restrict drug permeation and cellular accumulation to apical or basal
membrane domains.
The insensitivity of solid neoplasms to conventional chemo-
therapy has justly received considerable attention. It is
increasingly apparent that certain intrinsic cellular properties
of these tumour cells, often shared by the tissue of origin,
contribute to such insensitivity. In a survey of 20 human
colon carcinoma cell-lines (Chantret et al., 1988) the greater
majority were shown to possess the basic elements of epi-
thelial structure (cellular polarity including the formation of
distinct membrane domains, and formation of tight junctions
between cells) and even function (formation of a barrier by
restriction of free diffusion, and fluid filled blisters resulting
from transepithelial salt and water absorption). In two cases
the expression of histotypic differentiation (apical brush-
border, and brush-border specific hydrolases) was so extreme,
as to allow the use of such tumour cells as valid in vitro
models of the human intestinal epithelium.
P-glycoprotein is a 170-180 kDa membrane glycoprotein
associated with the phenomenon of pleiotropic (multidrug)
resistance (MDR). Immunohistochemical techniques have
demonstrated the presence of P-glycoprotein in the apical
membranes of several epithelia (Sugawara et al., 1988; Cor-
don-Cardo et al., 1990; Thiebaut et al., 1989; Thiebaut et al.,
1987), especially in the gastrointestinal tract, e.g., jejunum,
colon, liver (bile duct canaliculi), and pancreas, indicating
some intrinsic function (Cordon-Cardo et al., 1990). Retro-
viral transfection of a dog kidney epithelial cell-line (MDCK)
with mdrl cDNA results in polarised expression of P-glyco-
protein to the apical plasma membrane domain (Pastan et
al., 1988).
In many cases, tumours developing from epithelial tissues
tend to possess an innate resistance to the anticancer drugs
prior to any treatment regime being performed (Fojo et al.,
1987; Klohs & Steinkampf, 1988; Goldstein et al., 1989).
Thus it has been hypothesised that the P-glycoprotein is
involved in detoxification mechanisms, along with other
enzymic systems such as glutathione-S-transferases and cyto-
chrome P-450 (Deffie et al., 1988; Piller 1989), pumping
ingested toxins out of the cells into the lumen of the gastro-
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intestinal tract. A vectorial transport of substrate (vin-
blastine) in mdrl transfected MDCK cells has indeed been
demonstrated (Horio et al., 1989).
The exact mechanism by which the function of the
170-180 kDa glycoprotein mediates pleiotropic drug resis-
tance is not fully understood, but it is now broadly accepted
that reduced intracellular drug accumulation resulting from
increased active (ATP-dependent) drug efflux is an important
factor in the mechanism of resistance (Dano, 1973; Skovs-
gaard, 1978a; Skovsgaard, 1978b; Inaba et al., 1979). Vin-
blastine (and verapamil, see below) specifically bind to the
170-180kDa glycoprotein (Cornwell et al., 1986; Cornwell
et al., 1987; Safa et al., 1987), suggesting a functional correla-
tion between the levels of the membrane glycoprotein in
multidrug resistant cells and the level of binding of a specific
chemotherapeutic agent (Saga et al., 1986). The levels of
expression of the 170-180 kDa glycoprotein correlate with
the degree of drug resistance (Ueda et al., 1987; Van der
Bliek et al., 1988; Keizer et al., 1989). Calcium antagonists
(e.g., verapamil), calmodulin inhibitors (e.g., trifluoperazine)
and other agents (e.g., reserpine) inhibit the active drug efflux
and restore drug sensitivity in multidrug resistant cells
(Tsuruo, 1983; Kessel & Wilberding, 1984; Kessel & Wilber-
ding, 1985; Bellamy et al., 1988; Twentyman et al., 1986).
Although the precise mechanism of these agents is not yet
elucidated, their use provides a convenient functional
definition for P-glycoprotein-mediated fluxes in intact cells
and tissues.
test directly the hypothesis that expression of P-glycoprotein
is associated with transepithelial secretion (the generation of
a net flux of substrate in a basal-to-apical direction) of
MDR-substrates such as vinblastine sulphate in epithelial
tumour cells arising from the gastrointestinal tract. Secondly,
to determine whether the intrinsic expression of P-glyco-
protein in a functional context within a polarised epithelium
places constraints upon attempts to modify or circumvent
P-glycoprotein function, such as with the use of inhibitors.
In this study we have chosen two human adenocarcinoma
cell-lines, HCT-8 (human ileocaecal adenocarcinoma) and
T84 (human colonic adenocarcinoma). Both cell-lines demon-
strate considerable intestinal-like differentiation (Dharmsa-
thaphorn et al., 1984; Allen et al., 1991) and are capable of
forming epithelial monolayers when grown upon permeable
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matrices, so allowing the in vitro characterisation of trans-
epithelial solute fluxes concomitant with their biophysical
parameters (Madara et al., 1987; Chan et al., 1989).
Materials and methods
Cell culture
HCT-8 and T84 cells were obtained from the ATCC (Rock-
ville, Maryland 20852 USA). HCT-8 cells were maintained in
RPMI 1640 with 10% horse serum, 1 mM glutamine, 1 mM
sodium pyruvate, 40 IU ml-' penicillin and 40figml1I strep-
tomycin. T84 cells were grown in a 1: 1 mixture of Dulbecco's
modified Eagle's medium and Ham's F-12 with 5% newborn
calf serum and 200 IU ml-' penicillin, 200 ,g ml-l strep-
tomycin. It should be noted that the cell lines used in this
present study have not been selected for drug resistance
(Tompkins et al., 1974; Dharmsathaphorn et al., 1984).
Confluent monolayers were subcultured every 5-7 (HCT-8)
days or 14-16 days (T84), by treatment with 0.05% trypsin
and 0.02% EDTA in Ca2+-and Mg2+-free phosphate-
buffered saline (PBS). The cultures were incubated at 37°C in
a humidified atmosphere of 5% C02/95% air.
For uptake/efflux studies HCT-8 cells were seeded into
24-well Linbro plates (Costar) at a density of 4 x 105 cells/
well, and grown for 5 days under the above conditions, until
confluent monolayers were produced.
Functional epithelial layers of HCT-8 and T84 cells on
permeable supports were prepared essentially as described by
Dharmsathaphorn et al. (1984) and Simmons (1990). Cells
were seeded at high density (1 x 106 cells ml-', 3 ml well) into
rat-tail collagen coated filtercups, Transwell 24.5 mm diam.
(Costar) for HCT-8, or Anocell 25 mm diam. (Anotec) for
T84 cells. Filtercups were then cultured in 6-well plates at
37°C, 5% CO2 for 1 week or 1 month for HCT-8 and T84,
respectively, with medium replacement every 2-3 days. The
formation of functional epithelial layers was monitored by
the development of a significant transepithelial resistance
(R,), as measured using a WPI Evometer fitted with 'chop-
stick' electrodes to allow transepithelial current passage and
potential sensing (Simmons, 1990). Cell monolayers were
used when the transepithelial resistance typically exceeded
600 or 900 Q.cm2 for the HCT-8 and T84 cells, respectively
(values of resistance for filter cups, '300Q.cm2 are subt-
racted from all data).
Uptake/efflux of3H-vinblastine in HCT-8 cells
The growth medium was removed and the cell layers washed
rapidly by plunging into 51 PBS and the Linbro plates
blotted dry. Serum-free medium, 1 ml at room temperatue,
containing 10 nM [3H]-vinblastine sulphate, in the presence or
absence of 0.2 mM verapamil, was then added to each well.
Incubations for various times were performed at 37°C.
[3H]-Vinblastine uptake was terminated by removal of iso-
tope-containing medium, the plates were washed as described
above, and 0.5 ml trypsin/EDTA (0.05%/0.2%) solution
added. The resulting cell suspensions were collected into
scintillation vials. 3H-Activities (d.p.m.) were determined by
liquid scintillation counting (Beckman LS 5000CE spectro-
meter) using LKB 'Optiphase safe' scintillation cocktail.
Appropriate corrections were made for quenching effects.
A second group of cell layers were preloaded for 4 h with
10 nM 3Hvinblastine sulphate in 1 ml serum-free medium in
each well. Isotope-containing medium was then discarded
and the cell layers washed, as described above. Fresh serum-
free medium (1 ml) was then added to each well, either in the
absence or presence of 0.2 mM verapamil, and the cells incu-
bated for various times at 37°C. Following incubation the
amount of 3Hvinblastine contained within the cell layers was
determined exactly as described for the uptake measure-
ments.
Uptake/efflux of 3Hvinblastine is expressed relative to cell
contents at 4 h loading with 10 nM 3Hvinblastine; each incu-
bation condition was performed in quadruplicate.
Measurement ofbidirectional transepithelial [3H]-vinblastine
sulphatefluxes
Measurements of transepithelial solute flux were made essen-
tially as described by Simmons (1990). Functional epithelial
layers in filter cups were washed with 2 x 3 ml serum-free
medium and placed into fresh 6-well plates containing 3 ml
serum-free medium (basal solution), a further 3 ml serum-free
medium was then pipetted into the upper chamber (apical
solution) of the filter cup. Transepithelial resistance was
measured following 10 min incubation of the cells at 37°C, as
described above.
The medium on either the apical, or basal side of the
monolayers was then removed and replaced with 3 ml serum-
free medium containing 10 nM [3H]-vinblastine sulphate in the
apical (a) or basal (b) solutions, in the presence or absence of
0.2 mM verapamil, followed by incubation at 37°C. The con-
centration of vinblastine was chosen to be considerably
below the Km for vinblastine transport (Horio et al., 1991)
and therefore well within the first-order part of the saturation
curve, while the concentration of verapamil was chosen to
completely block P-glycoprotein function. In order to
measure the bidirectional fluxes of vinblastine sulphate (Jab,
flux from apical to basal solutions, and Jsa, flux from basal
to apical solutions), 100gll samples ofmedium from each side
of the monolayer were taken at regular intervals, 3H activities
in these samples were then measured as described above.
Each incubation was performed at least in triplicate. On
completion of the experiments, the filter cups were washed by
immersion in 11 PBS, the filters removed from their holders
and placed into scintillation vials and 3H activities deter-
mined.
Inulin is a high molecular weight (-5,000) inert macro-
molecule which is normally excluded from cells, and is
therefore used as a tracer of extracellular permeability path-
ways through the intercellular tight junctions, and an indi-
cator of changes in the permeability of this paracellular
pathway (Madara & Dharmsathaphorn, 1985). Bidirectional
['4C]-inulin fluxes were determined exactly as for vinblastine
sulphate fluxes.
Assessment ofmitochondrial enzymefunction: MTTassay
Cells were seeded onto 96-well plates (10,000 cells/well) and
the monolayers were allowed to grow over the following
48 h. The cells were washed with 100iLl PBS before addition
of verapamil (0-500 iM) or vinblastine (0-200nM). Stock
solutions of verapamil were freshly prepared in dimethyl
sulphoxide at a concentration of 10mgml-', followed by
dilution in serum-free medium. Control wells were included
in each plate (each solution contained the same concentration
of DMSO). Cells were then incubated for either 1 or 5 h
under cell culture conditions. On completion of the incuba-
tion, 50gl of MTT reagent (consisting of 5 mg 3-[4,5-dime-
thylthiazo-2-yl]-2,5-diphenyltetrazolium bromide and 1.5 mg
phenazine methosulphate per 5 ml PBS) was added to each
well. The plates were then incubated for a further 20 min at
37°C. The cell monolayers were fixed by the further addition
of 100glA of buffered formalin, pH 7.0, to each well for 1 h.
After overnight drying in air, the formazan product was
extracted by addition of 100pl acidified isopropanol to each
well (1 ml 1 M HCI acid per 100 ml isopropanol) before
absorbance at 570 nm was measured with a Dynatech
MR700 ELISA plate reader (Allen et al., 1991).
Assessment oflysosomal integrity: neutral red assay
Cells were plated onto 96-well plates and incubated with
verapamil as described above, following incubation the solu-
tions were removed and the cells washed with 100pl PBS/
well. The cells were then incubated for 3 h with 200fsl neu-
tral red (50,tg ml1' freshly prepared in serum-free medium).
The monolayers were fixed by the addition of 100 il 1%
formalin containing 1% CaCl2 for 2-3 min. This solution
was then discarded and the plates were allowed to dry in air
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acetic acid, 50% ethanol (1001l per well) over a period of
45 min with shaking. Absorbance was measured at 540 nm
with an ELISA plate reader (Allen et al., 1991).
Immunoprecipation ofP-glycoprotein
Immunoprecipitates of the P-glycoprotein were prepared
essentially as described by Hamada et al. (1987). Briefly,
5 x 107 cells were detached by scraping, washed in ice cold
0.15M NaCl, 0.02M sodium phosphate buffer, pH 7.4, and
centrifuged at 1,000g to form a cell pellet. The cell pellets
were resuspended in 10 ml buffer S (50 mM Tris/HCl (pH 8),
140 mm NaCl, 5 mM NaF, 2 mM sodium vanadate, 0.2 mM
PMSF, 0.25 Lgml-' aprotinin, 4 mM EDTA, 0.5% sodium
deoxycholate) and incubated on ice for 30 min. The suspen-
sions were clarified by centrifugation at 10,000g for 20 min.
An aliquot, 4ml, of this cell extract was then incubated with
100 ytl monoclonal antibody to P-glycoprotein, JSB-l
(Scheper et al., 1988), with shaking for 2 h at 4°C. Protein
A-Sepharose CL-4B, 200pl, was then added (25% v/v in
buffer S) and incubated for a further 30 min at 4°C with
shaking. A pellet was formed by centrifugation (400g for
2 min), and this pellet was washed five times with 2 ml ice
cold buffer S before 150p1 sample buffer (Laemmli, 1970)
was added and the precipitates analysed by SDS-polyacryl-
amide gel electrophoresis using 5-15% linear gradient gels
(Laemmli, 1970). Gels were fixed and stained using a method
as described by Thompson (1987).
Materials
[3H]-vinblastine sulphate and ['4C]-inulin were purchased from
Amersham International plc (Little Chalfont, Amersham,
Bucks). The scintillation cocktain 'Optiphase safe' and
Protein-A Sepharose CL-4B were obtained from Phamacia
LKB Biotechnology Ltd (Milton Keynes, Bucks). All tissue
culture media and reagents (Gibco BRL) and tissue culture
plastics (Nunc) were supplied by Life Technologies Ltd
(Paisley, Scotland). The filter cups used for this study were as
follows: for HCT-8 cells Transwells for 6-well plates, with
0.4 ym pore size and 24.5 mm diam (Costar Nucleopore UK
Ltd, High Wycombe, Bucks); for T84 cells, Anocell 25 tissue
culture inerts, with 0.2ltm pore size and 25 mm diam (Ano-
tec Separations Ltd, Oxon). The monoclonal antibody JSB-1
was purchased from Sera-lab Ltd (Crawley Down, Sussex),
all other chemicals were obtained from Sigma Chemical Co
(Poole, Dorset) or BDH Chemicals Ltd (Poole, Dorset).
Results
Cellular vinblastine uptake andefflux in HCT-8 cells
With HCT-8 cells grown as monolayers on plastic plates,
cellular uptake and loss ofvinblastine sulphate (Figure 1) will
represent the relative rates of influx and efflux mainly across
the apical cell border. Vinblastine accumulation in HCT-8
cells appeared bi-phasic and did not approximate to first-
order kinetics. Verapamil increased the extent of cellular
uptake of vinblastine by 38% at 5 h (Student's t-test,
P<0.05; Figure la). Vinblastine loss from HCT-8 cell
monolayers occurred only after a delay of approximately
60 min (Figure lb). Verapamil inhibited vinblastine loss from
preloaded cells by 38% at 3 h (Student's t-test, P<0.05;
Figure lb). The time-dependent increase in accumulation of
vinblastine and the inhibition ofvinblastine loss by verapamil
are thus consistent, i.e., the expression of a verapamil-
sensitive efflux of vinblastine across the apical cell border.
Similar experiments with T84 cells were not possible due to
the detachment of cells with washing.
Epithelialproperties offilter-grown cell layers
HCT-8 cells when grown to confluency in permeable filter
cups developed a transepithelial electrical resistance of
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Figure 1 Cellular a, uptake and b, efflux of ['H]-vinblastine sul-
phate in HCT-8 cells grown on plastic. Results are illustrated as
the mean, with error bars of 1 s.e. (where error bars are not seen
1 s.e. <size of symbols used), vinblastine content expressed as a
percentage of the total cell content, where 100% = total amount
of [3H]-vinblastine sulphate in cells after a 4 h incubation with
drug, for four observations on the same plate. Vinblastine uptake
was not significantly different in the absence or presence of
verapamil (P= 0.105), while vinblastine efflux was significantly
greater in the presence of verapamil (P<0.001), as analysed by
two-way analysis of variance. Results are illustrative of 4-5
separate experiments.
746.5 ± 47.9 Q-cm' (n = 70) after 7 days in culture. T84 cells
reached a transepithelial electrical resistance of 1028.9 +
36.1 Q.cm2 (n = 25) after 28-35 days of growth. These values
are characteristic of 'tight' epithelia such as the colon. HCT-8
and T84 cells display a small potential differences (Vt), basal
electropositive, of 1.0 (HCT-8) or 0.4 mV (T84) when grown
under these conditions (Chan et al., 1989) indicating the
development of functional ion (Na+, Cl-) transepithelial
transport.
Transepithelial vinblastineflux
Using these functional HCT-8 and T84 epithelial layers,
time-dependent movement of vinblastine sulphate was
measurable, both in the apical-to-basal and basal-to-apical
directions (Figure 2). The basal-to-apical flux (Jb.a) was
0.234±0.007 (n=6) and 0.547±0.012 (n= 12) pmolh'-
cm-2, and this exceeded the apical-to-basal flux (Ja.b) of
0.099 ± 0.008 (n = 7) and 0.095 ± 0.017 (n = 4) pmol h-'
cm'2, in the HCT-8 and T84 epithelial layers, respectively. A
net flux (net = J Ja-b) was, therefore, observed in the
basal-to-apical direction for both cell lines. The magnitude of
the directional net flux being 0.135 and 0.452 pmol h-' cm-I
for HCT-8 and T84, respectively, which is 1.4- or 5.75-fold
greater than the unidirectional flux in the apical-to-basal
direction for these cell layers. The net flux cannot be
accounted for by the small electrical potential differences
maintained by the epithelial layers in the experimental condi-
tions used.
Transepithelial electrical resistance was not compromised
over the time course of the experiments. A slight increase in
R, was observed in both cell lines as they became equilibrated
to the fresh medium; from 746.5 ± 47.9 (n = 70) to 839.3 +
c
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Figure 2 Transepithelial vinblastine sulphate fluxes measured in
a, HCT-8 and b, T84 cells. Mean, with error bars of I s.e.,
3Hvinblastine flux was measured in the basolateral-to-apical (B-
A: HCT-8, n = 6; T84, n = 12), apical-to-basolateral (A-B: HCT-
8, n = 7; T84, n = 4), and in the basolateral-to-apical direction in
the presence of 0.2 mM verapamil (B-A verapamil: HCT-8,
n = 16; T84, n = 5). The line illustrates the least squares best fit to
the data, the slopes of which give the vinblastine flux. Data are
from five different experiments.
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Figure 3 Scatter diagram of apparent permeabilities of vinblas-
tine sulphate in HCT-8 (X) and T84 (A) epithelial layers plotted
against transepithelial electrical resistance. The apparent per-
meability (Jab/C), calculated as the flux of vinblastine Ja-b +
vinblastine concentration, has units of cm h-'.
'tightness' of the epithelium (i.e. the extent of the non-cellular
(paracellular or junctional) pathway for solute permeation).
For T84 and HCT-8 epithelia it is clear that the unidirec-
tional apparent permeability for apical-to-basal flux (Ja.b/C) iS
inversely related to Rt. This relationship is entirely consistent
with a parallel permeation pathway model for vinblastine
sulphate, in which a cellular (hydrophobic) rate at limiting
resistance values (<600k -cm2) is present together with a
paracellular (hydrophilic) rate (see Figure 5). The decrease in
electrical resistance seen with verapamil in T84 epithelial
layers is thus correlated with increased 'leakage' of vinblas-
tine sulphate via a paracellular route.
46.1 Q cm2 (n = 42), and from 1028.0 ± 36.1 (n = 25) to
1241 ± 52.6 Qcm2 (n = 12) in the HCT-8 and T84 cell layers,
respectively. Thus, vinblastine sulphate, at the concentrations
used, did not materially alter the barrier formed by the
HCT-8 and T84 cells.
The integrity of this barrier in HCT-8 cells was also eval-
uated using ['4C]-inulin flux, in parallel with the vinblastine
sulphate measurements. After 200 min using a concentration
of 1 gM ['4C]-inulin, the apparent permeability (J/C; i.e., inulin
flux per cm2 . initial concentration ofinulin) was 2.74 x 10-4
(Ja.b) and 1.82 x 10-4 (Jb.a) cm h-'; that is an order ofmagni-
tude lower than that seen for vinblastine flux (see below and
Figure 3).
Verapamil, at a concentration of 0.2 mM, reduced the net
transport of vinblastine sulphate across the epithelial cell
layers, primarily by an approximate 50% reduction in basal-
to-apical flux in both cell lines (Figure 2). This effect was
similar with verapamil added to either the apical or baso-
lateral solutions; e.g. in HCT-8 cell layers, Jab was 0.102 +
0.006 (n = 8) and 0.126 ± 0.001 (n = 6) with basal and apical
verapamil, respectively, giving an average flux of 0.110+
0.004 (n = 14) pmol h' cm2 illustrated in Figure 2a.
In the presence of verapamil, 0.2 mM, for 300 min the
transepithelial electrical resistance fell from control values of
839.3 ± 46.1Qcm2 (n = 42) to 656.8 ± 68.2Qcm2 (n = 9) in
the HCT-8 cell layers, a decrease of 21.7%. In the T84 cell
layers, a 73.9% decrease in R, was observed, from 1241.1 +
52.6 (n = 12) to 323.5 ± 62.6 Q cm2 (n = 6). The verapamil-
dependent decrease in electrical resistance correlates with the
extent of drug leak across the T84 epithelial layers, reducing
the apparent inhibitory effect of verapamil on the basal-to-
apical flux (Figure 2b).
Figure 3 illustrates a scatter diagram of the apparent
permeability of vinblastine sulphate (from individual data for
Ja-b) in T84 and HCT-8 epithelial layers plotted against the
transepithelial electrical resistance (Rt). Rt is a measure of the
Cell-associated vinblastine content
The levels of cell-associated vinblastine sulphate after 200
min incubation was dependent on several factors, including
the side of the cell layer exposed to the drug. A significantly
increased vinblastine level was measured in those cell layers
exposed to the drug from the basolateral surface compared
to the apical surface (Table I). In the HCT-8 cells cellular
vinblastine content was 1.8-fold greater when loading was
from the basal side. In the T84 cells, the cellular vinblastine
content was approximately 5-fold greater with basal loading.
These differences cannot be explained by tracer binding to
the filter matrix on which the cells are grown.
In the HCT-8 cell layers no difference was seen in cellular
vinblastine content as a consequence of apical or basal
exposure until the transepithelial electrical resistance of the
layers exceeded -300 Q cm2, For example, when HUT-8 cell
layers with an average resistance of 298.5 ± 32.1 Q cm2
(n = 4) were loaded with vinblastine sulphate, as above, the
cell associated drug was found to be either 0.111 pmolcm2
(n = 2) (drug presented apically) or 0.107pmolcm2 (n = 2)
(drug presented basally); i.e. no difference. This implies that
access of vinblastine sulphate to either epithelial surface
occurs, whether label is present in apical or basal solutions in
low resistance (leaky or incomplete) layers.
Table I Levels of cell-associated vinblastine sulphate
Cell-associated vinblastine (pmolcm-2)
Cell line Verapamil Apical loading Basal loading
HCT-8 - 0.147 0.006 (n = 13) 0.269 0.029 (n = 12)
HCT-8 Basal 0.174±0.011(n=3) 0.183±0.011(n=3)
HCT-8 Apical 0.136±0.012 (n = 3) 0.328±0.025 (n = 3)
T84 - 0.260 0.042 (n = 3) 1.310 0.154 (n = 6)
Values are expressed as mean± 1 s.e. cell-associated vinblastine
contentafter5 hincubationwith 10 nMvinblastine.Verapamil, 0.2 mM
was added to basal or apical surface as indicated.
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Verapamil was found to decrease the vinblastine content of
the cells by approximately 14%, when presented together
with the radioligand on the basolateral surface of the cell
layer (Table I). In contrast, a 29% increase in cell vinblastine
content was observed when verapamil was presented on the
apical surface, with [3H]-vinblastine on the basolateral surface
(Table I). No significant difference in the lower levels of
cellular vinblastine loading with apical presentation was evi-
dent as a result of verapamil treatment (Table I).
Assessment ofacute verapamil and vinblastine toxicity
A high concentration of verapamil was employed in these
experiments to inhibit P-glycoprotein function. In prelim-
inary experiments in HCT-8 and MDCK cells, verapamil,
200jLM, was required to reduce the basal-to-apical flux of
vinblastine to that of the passive apical-to-basal flux rate, i.e.
100% inhibition (e.g., see Figure 2a). HCT-8 cells showed no
reduction in viability upon incubation for 5 h, the maximum
duration of the flux experiments, with concentrations of
verapamil upto and including 200gAM (Figure 4a). However,
at higher concentrations, above 300gM, the reduction of
formazan dye was increased, consistent with an increased
cellular permeability to the MTT reagent, with no evidence
of reduction in mitochondrial enzyme function. Acute incu-
bation with vinblastine, 0.1-200 nM, for 5 h did not effect
HCT-8 cell viability assessed by the MTT assay. Similar
exposure of the cells to vinblastine followed by removal of
the vinblastine, and culture for a further 48 h, is, however,
associated with a reduction of formazan dye production,
consistent with the well recognised cytostatic action of this
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drug (J. Hunter, C.N. Allen, N.L. Simmons & B.H. Hirst,
unpublished data).
Using the neutral red assay to assess toxicity (Figure 4b), a
relatively low concentration of verapamil, 20tM, was assoc-
iated with an approximate 20% reduction in lysosomal and/
or plasma membrane permeability, but this was not reduced
further by increasing concentrations of verapamil.
Immunoprecipitation ofP-glycoprotein
Immunoprecipitation of whole cell extracts (same cell number)
of HCT-8 and T84 with the monoclonal antibody JSB-1
followed by SDS-PAGE analysis yielded the protein band
patterns seen in Figure 5. A single diffuse band was detected
by silver staining, with a Mr value of 170-180 kDa consistent
with expression of P-glycoprotein in both cell types. It is also
clear from the gel that a greater amount of the protein is
present within T84 cells when compared to HCT-8 cells. No
high M, bands were visible on gels if either the JSB-1 anti-
body or the cell extracts were omitted.
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Figure 4 Changes in a, mitochondrial enzyme activity (MTT)
and b, neutral red uptake in HCT-8 cells after incubation with
various concentrations of verapamil for 5 h. Results are illus-
trated as the mean, with error bars of 1 s.e. (n = 8), MTT activity
or neutral red uptake expressed as a percent of control activities
in the absence of verapamil.
Figure 5 Demonstration of P-glycoprotein in HCT-8 and T84
cells. Silver-stained SDS-polyacrylamide gels of immunoprecip-
itates (with monoclonal antibody JSB-l) of cell extracts of HCT-
8 or T84 cells. Mr values indicate the position of Sigma high MW
markers (kDa), while the arrow indicates a M, of 170 kDa.
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Vinblastine secretion in intestinal adenocarcinoma epithelial cells
In polarised monolayers of epithelial cells formed by two
separate human intestinal adenocarcinomas cell-lines (T84
and HCT-8), we have demonstrated net secretion of vinblas-
tine sulphate from basal to apical cell surfaces. A model
illustrating the features of the net flux is presented in Figure
6. There are several lines of evidence to suggest that this net
secretory flux is the functional result of P-glycoprotein ex-
pression in T84 and HCT-8 cells. Firstly, immunoprecipita-
tion of protein from both cell types of monoclonal antibody
JSB-1 results in a protein that has a molecular mass entirely
consistent with the mdrl gene product (Figure 5). Secondly,
in cells grown upon plastic substrate, a component of cellular
efflux of vinblastine sulphate is inhibited by verapamil, whilst
loading of cells by vinblastine is increased by verapamil
(Figure 1). Thirdly, net secretory flux is itself inhibited by
verapamil (Figure 2). Finally, the increased amount of P-
glycoprotein expression detected in T84 cells (Figure 5) cor-
relates with the greater vinblastine flux asymmetry in this
cell-line (Figure 2). In a study of vectorial transport of
vinblastine by dog kidney cells transfected with a retroviral
vector containing mdrl, increased vectorial transfer was seen
upon transfection (Horio et al., 1989). The present data are,
therefore, the first direct demonstration in favour of the
hypothesis that the function of mdrl in epithelia from the
gastrointestinal tract is to promote detoxification by a pro-
cess of epithelial secretion.
Determination of expression of P-glycoprotein by immuno-
precipitation relies on the use of monoclonal antibody JSB-1
which recognises a highly conserved epitope, most probably
on a cytoplasmic domain of the protein (Scheper et al.,
1988). Monoclonal antibody C219 also recognises a cytoplas-
mic epitope of the protein (Kartner et al., 1985). In our
hands antibody C219 weakly immunoprecipitates a band of
circa 170 kDa, but in addition a number of other major
bands are present in the immunoprecipitate suggesting that
the epitope recognised by C219 is not unique to P-glyco-
protein, even in non-muscle cells (Thiebaut et al., 1989).
Previous studies on HCT-8 cells have shown that although
verapamil increases adriamycin accumulation and cytotoxi-
city, surface labelling failed to detect a glycoprotein of appro-
priate molecular size due to the insensitivity of the technique
(Klohs & Steinkampf, 1988). The exact cellular location of
P-glycoprotein in HCT-8 and T84 cells has not been deter-
mined, but the presence of vectorial transepithelial transport
of vinblastine is consistent with a polarised expression to the
apical cell surface. It should be noted that Broxterman et al.
(1989) localised a significant portion of cellular immuno-
fluorescence in drug resistant cells to intracellular vesicular
structures. Active drug accumulation into an endomembrane
(acidic) vesicular compartment, with subsequent exocytotic
release at the cellsurface has been implicated in P-glyco-
protein mediated drug efflux (Beck, 1987). The non-first
order kinetic behaviour of vinblastine accumulation and
efflux in HCT-8 cells (Figure 1) would be consistent with
such a mechanism. Vesicular accumulation of vinblastine
would not preclude vectorial transfer across the epithelal
monolayer, provided that such vesicular traffic was polarised
with final delivery to the apical membrane (Figure 6).
Polarisation in endocytotic trafficking mechanisms from the
apical and basolateral surfaces has been demonstrated in
Caco-2 colonic adenocarcinoma cells (Hughson & Hopkins,
1990). It has also been reported that a significant transcytosis
(bulk directional transcellular transport by a population of
endocytotic vesicles) of extracellular marker compounds
exists in Caco-2 cells, oriented from basal to apical cell
surfaces (Heyman et al., 1990). Could such a mechansim
account for the vectorial transfer of vinblastine reported
here? Direct determination of bidirectional inulin fluxes
showed that these are at least an order of magnitude less
than those of vinblastine, and non-vectorial in nature,
demonstrating that an active accumulation must exist even
with a vesicular model for transepithelial vinblastine permea-
tion.
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Figure 6 Model for vinblastine secretion across intestinal adeno-
carcinoma epithelial cell layers. The passive permeability of the
apical and basolateral membranes, and junctional complexes
(tight junctions; tj) are illustrated, which together with active
apical vinblastine efflux mediated via P-glycoprotein (@), give
rise to the bidirectional fluxes(Ja-b <Jb-a) resulting in a net flux (Jne,) in the basal-to-apical direction. Possible vectorial transport
via a vesicular compartment is illustrated. The diagram also
illustrates the three sites (a,b,c) of action of verapamil (Vp)
idenified in the present study.
The present data lend support to the linkage between the
intrinsic drug resistance of colon tumours and a detoxifi-
cation mechanism present within normal cells (Klohs &
Steinkampf, 1988; Horton et al., 1989). Additionally, the
demonstration of net vinblastine transport across an epithe-
lial layer in which the basal bathing solution is progressively
depleted of vinblastine suggests that an epithelial surface
formed within a solid tissue mass or multicellular spheroid
could generate a compartment that was relatively depleted of
cytotoxic drug (Nederman & Twentyman, 1984). Thus, cells
displaying epithelial junction formation and P-glycoprotein
expression could confer 'resistance' to an enclosed non-differ-
entiated cell population. Little direct experimental data is
available at present to support this contention, but we note
that epithelial 'spheroids' composed of an outer differentiated
cell-layer enclosing a progressively de-differentiated cell mass
are considered, by some, as more realistic models of solid
tumour cell systems (Nederman & Twentyman, 1984). In
colonic tumours in situ, P-glycoprotein expression was
inhomogeneous in the tumour, but was enhanced at the
luminal membrane face (Cordon-Cardo et al., 1990); in situa-
tions where a tumour mass and invasion front into underly-
ing tissue could be defined, P-glycoprotein has been reported
to be preferentially localised in cells at the invasion front
(Weinstein et al., 1990).
The reconstitution in vitro of intestinal epithelial function
in monolayer culture in filter cups allows experimental access
to both relevant cell surfaces and provides a convenient
system to test cytotoxic regimes. Of special interest in this
context are polar compounds that may be subject to signifi-
cant diffusion restriction by the formation of a 'tight' epithe-
lial barrier (Madara et al., 1987). Thus inulin possesses an
extremely low permeability in comparison to vinblastine,
whose transepithelial permeability is likely to be predom-
inantly transcellular in such highly resistive layers. It should
be noted that as epithelial resistance decreases, apical-to-
basal vinblastine permeability increases, suggesting that signi-
ficant diffusion via a non-cellular polar route (the paracel-
lular route) occurs (see Figure 3). This result suggests that if
significant diffusion restriction occurs by tight junction
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formation within a solid tumour mass, enhanced drug per-
meation could be achieved by agents or drugs disrupting
epithelial junction integrity (Figure 6). Of interest in this
context is the marked reduction in transepithelial resistance
of T84 epithelial layers upon incubation with verapamil that
is coincident with enhanced apical-to-basal 'leak' flux of
vinblastine.
An additional facet of the expression of an epithelial
phenotype is the existence of separate apical and basolateral
plasma membrane domains with a unique lipid and integral
membrane protein composition (Simons & Fuller, 1985).
Also membrane amplification (via the presence of a brush-
border or extensive interdigitations ofthe basolateral surface)
can significantly alter the effective surface areas for drug
diffusion into the cytosol. In the extensively studied MDCK
dog kidney cell-line, careful morphometric data show that
the basolateral surface area exceeds that of the apical mem-
brane by 7-10-fold (von Bonsdorff et al., 1985; Lamb et al.,
1981). For epithelial colonic adenocarcinoma cells grown
upon plastic the basolateral surface will be inaccessible from
the apical medium due to tight-junction formation. The pre-
sent data show that the cellular vinblastine content, and the
effect ofinhibitors, depends upon whether the cells are grown
upon plastic or a permeable matrix. In epithelial layers on a
permeable matrix, vinblastine content also depends upon the
surface from which the drug is presented; with basolateral
presentation, cellular vinblastine is higher than with apical
presentation (Table I). This implies that with a constant
pump rate via P-glycoprotein, overall drug permeation via
the basolateral membrane exceeds that of the apical surface
due to differences in membrane area and/or lipid composi-
tion. Verapamil reduced cell-associated vinblastine when
presented from the basal surface, with vinblastine also pres-
ented basally (Table I), presumably by reducing drug influx,
since inhibition of P-glycoprotein mediated efflux alone
would increase cell vinblastine. Verapamil was equally effec-
tive from either epithelial surfaces in inhibition of vectorial
transepithelial vinblastine transport, suggesting that vera-
pamil access to P-glycoprotein was not limited by apical or
basolateral membranes.
The present data emphasise the potential importance of the
expression of epithelial characteristics in intestinal adenocar-
cinoma cells towards an understanding of the biology of a
tumour in vivo. P-glycoprotein function within an epithelial
adenocarcinomal sheet generates net solute (vinblastine) flux
consistent with its tissue of origin. Cellular accumulation of
vinblastine within an epithelial sheet is not solely dependent
upon P-glycoprotein function, and this study highlights the
importance of differential membrane and junctional perme-
abilities (Figure 6). It is recognised that a variety of mecha-
nisms are involved in mediating the modulation of MDR by
chemosensitisers such as verapamil. In addition to inhibiting
P-glycoprotein-mediated drug efflux, verapamil has also been
described as inhibiting the ATP-dependent efflux of other
xenobiotics such as bis-carboxyethyl-carboxyfluorescein
(Allen et al., 1990) and methotrexate (Sirotnak & O'Leary,
1991). In the present study our primary purpose has been to
define P-glycoprotein-mediated flux in epithelial layers. The
use of high concentrations of verapamil was necessitated by
the requirement to inhibit maximally and rapidly P-glyco-
protein pump activity. Non-specific effects of verapamil on
epithelial function (e.g., intercellular junctional permeability)
and cellular membrane permeability were noted (Figure 4b
and 6), but these were not associated with acute toxicity
assessed in the MTT assay. However, it is recognised that the
chemosensitising action of verapamil is likely to be multifac-
torial, and may include perturbation of plasma membranes
or lysosomal function, alterations in calcium homoeostasis,
inhibition of other intracellular regulatory mechanisms (Ford
& Hait, 1990), as well as interaction with P-glycoprotein.
We wish to thank the North of England Cancer Research Campaign
for generous financial support for this work.
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